BioBeats, the AI-powered health tech platform for improving well being, has raised $3M in funding from investors that include IQ Capital Partners, Oxford Sciences Innovation, and White Cloud Capital. Founded in 2012 by David Plans, Davide Morelli, and Nadeem Kassam, BioBeats has now raised a total of $6.6M in funding over six funding rounds.
For BioBeats, our vision is to disrupt the way stress is viewed and treated on a global scale. Our approach focuses on challenging the conventional approach to addressing the pandemic of stress and its relation to mental health, cardiovascular disease, and other poor health outcomes; we are truly at a turning point in the digital health revolution, and this latest round of funding will help us achieve remarkable advances for our platform – Dr. David Plans, Founder and CSO of BioBeats
